InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $181.480 2.24 (1.25%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18,959 PME FY Results release date and webcast briefing 20 Jul 2023 9:21AM $65.750 $181.480 risen by 176.02%
$18,959 PME signs 7-year, $20M contract with Gundersen Health System 16 May 2023 9:12AM $60.200 $181.480 risen by 201.46%
$18,959 Notification of buy-back - PME 3 Apr 2023 8:59AM $63.870 $181.480 risen by 184.14%
$18,959 Update - Notification of buy-back - PME 31 Mar 2023 9:47AM $64.610 $181.480 risen by 180.89%
$18,959 Change of Company Secretary 27 Mar 2023 9:44AM $64.990 $181.480 risen by 179.24%
$18,959 PME Cleansing Notice - Sam Hupert 16 Mar 2023 10:01AM $62.220 $181.480 risen by 191.67%
$18,959 PME Cleansing Notice - Anthony Hall 16 Mar 2023 10:00AM $62.220 $181.480 risen by 191.67%
$18,959 Change of Director's Interest Notice - Sam Hupert 16 Mar 2023 9:47AM $62.220 $181.480 risen by 191.67%
$18,959 Change of Director's Interest Notice - Anthony Hall 16 Mar 2023 9:46AM $62.220 $181.480 risen by 191.67%
$18,959 Sale of 1M shares each by founders 16 Mar 2023 9:46AM $62.220 $181.480 risen by 191.67%
$18,959 Change of Director's Interest Notice 14 Mar 2023 8:17AM $61.140 $181.480 risen by 196.83%
$18,959 Sale of Shares - Chairman 14 Mar 2023 8:17AM $61.140 $181.480 risen by 196.83%
$18,959 No exposure to Silicon Valley Bank (SVB) 13 Mar 2023 9:40AM $61.380 $181.480 risen by 195.67%
$18,959 HY23 Results Presentation 15 Feb 2023 11:09AM $66.670 $181.480 risen by 172.21%
$18,959 CEO Interview - 1H23 results 15 Feb 2023 9:58AM $65.050 $181.480 risen by 178.99%
$18,959 Dividend/Distribution - PME 15 Feb 2023 9:30AM $65.050 $181.480 risen by 178.99%
$18,959 Company Announcement - Interim Results 15 Feb 2023 9:23AM $65.050 $181.480 risen by 178.99%
$18,959 Appendix 4D 15 Feb 2023 9:21AM $65.050 $181.480 risen by 178.99%
$18,959 Half Year Accounts 15 Feb 2023 9:20AM $65.050 $181.480 risen by 178.99%
$18,959 PME signs A$12M, 8 year deal with Samaritan Health 30 Jan 2023 9:30AM $65.100 $181.480 risen by 178.77%
$18,959 PME HY Results release date and webcast briefing 24 Jan 2023 9:12AM $63.230 $181.480 risen by 187.02%
$18,959 PME signs A$25M, 7 year deal with University of Washington 20 Jan 2023 9:37AM $61.000 $181.480 risen by 197.51%
$18,959 PME signs A$15M, 7 year deal with Luminis Health 22 Dec 2022 10:00AM $54.280 $181.480 risen by 234.34%
$18,959 Results of AGM - 2022 21 Nov 2022 12:39PM $59.370 $181.480 risen by 205.68%
$18,959 AGM Presentation - 2022 21 Nov 2022 10:28AM $58.620 $181.480 risen by 209.59%

226 - 250 of 679 results

Page 10 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.